Paion AG

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, MRK.DE has a market cap of 47.8B. Regarding current trading prices, PA8.F is priced at €0.04, while MRK.DE trades at €109.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas MRK.DE's P/E ratio is 18.32. In terms of profitability, PA8.F's ROE is +0.00%, compared to MRK.DE's ROE of +0.09%. Regarding short-term risk, PA8.F is less volatile compared to MRK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check MRK.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, ZOE.DE has a market cap of 44.8B. Regarding current trading prices, PA8.F is priced at €0.04, while ZOE.DE trades at €102.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas ZOE.DE's P/E ratio is 19.30. In terms of profitability, PA8.F's ROE is +0.00%, compared to ZOE.DE's ROE of +0.58%. Regarding short-term risk, PA8.F is less volatile compared to ZOE.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check ZOE.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, 2M7C.F has a market cap of 3.6B. Regarding current trading prices, PA8.F is priced at €0.04, while 2M7C.F trades at €1.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas 2M7C.F's P/E ratio is 18.38. In terms of profitability, PA8.F's ROE is +0.00%, compared to 2M7C.F's ROE of +0.01%. Regarding short-term risk, PA8.F is less volatile compared to 2M7C.F. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check 2M7C.F's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, DMP.DE has a market cap of 2.5B. Regarding current trading prices, PA8.F is priced at €0.04, while DMP.DE trades at €47.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas DMP.DE's P/E ratio is 21.60. In terms of profitability, PA8.F's ROE is +0.00%, compared to DMP.DE's ROE of +0.19%. Regarding short-term risk, PA8.F is less volatile compared to DMP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check DMP.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, EVT.DE has a market cap of 792.1M. Regarding current trading prices, PA8.F is priced at €0.04, while EVT.DE trades at €4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas EVT.DE's P/E ratio is -4.95. In terms of profitability, PA8.F's ROE is +0.00%, compared to EVT.DE's ROE of -0.18%. Regarding short-term risk, PA8.F is less volatile compared to EVT.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check EVT.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, 2HQ0.DE has a market cap of 621M. Regarding current trading prices, PA8.F is priced at €0.04, while 2HQ0.DE trades at €5.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas 2HQ0.DE's P/E ratio is -0.26. In terms of profitability, PA8.F's ROE is +0.00%, compared to 2HQ0.DE's ROE of -1.15%. Regarding short-term risk, PA8.F is less volatile compared to 2HQ0.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check 2HQ0.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, PSG.DE has a market cap of 333.9M. Regarding current trading prices, PA8.F is priced at €0.04, while PSG.DE trades at €29.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas PSG.DE's P/E ratio is 17.26. In terms of profitability, PA8.F's ROE is +0.00%, compared to PSG.DE's ROE of +0.44%. Regarding short-term risk, PA8.F is less volatile compared to PSG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check PSG.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, 21P.F has a market cap of 167M. Regarding current trading prices, PA8.F is priced at €0.04, while 21P.F trades at €2.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas 21P.F's P/E ratio is -3.12. In terms of profitability, PA8.F's ROE is +0.00%, compared to 21P.F's ROE of -0.13%. Regarding short-term risk, PA8.F is less volatile compared to 21P.F. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check 21P.F's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, HAEK.DE has a market cap of 111.5M. Regarding current trading prices, PA8.F is priced at €0.04, while HAEK.DE trades at €21.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas HAEK.DE's P/E ratio is 11.57. In terms of profitability, PA8.F's ROE is +0.00%, compared to HAEK.DE's ROE of +0.06%. Regarding short-term risk, PA8.F is less volatile compared to HAEK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check HAEK.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, APPH.DE has a market cap of 91.6M. Regarding current trading prices, PA8.F is priced at €0.04, while APPH.DE trades at €11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas APPH.DE's P/E ratio is 137.50. In terms of profitability, PA8.F's ROE is +0.00%, compared to APPH.DE's ROE of +0.02%. Regarding short-term risk, PA8.F is more volatile compared to APPH.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PA8.F.Check APPH.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, 93M1.DE has a market cap of 82M. Regarding current trading prices, PA8.F is priced at €0.04, while 93M1.DE trades at €18.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas 93M1.DE's P/E ratio is -0.71. In terms of profitability, PA8.F's ROE is +0.00%, compared to 93M1.DE's ROE of -0.48%. Regarding short-term risk, PA8.F is less volatile compared to 93M1.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check 93M1.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, 2HQ.DE has a market cap of 78.9M. Regarding current trading prices, PA8.F is priced at €0.04, while 2HQ.DE trades at €0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas 2HQ.DE's P/E ratio is -0.03. In terms of profitability, PA8.F's ROE is +0.00%, compared to 2HQ.DE's ROE of -1.15%. Regarding short-term risk, PA8.F is less volatile compared to 2HQ.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check 2HQ.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, B8F.DE has a market cap of 20.7M. Regarding current trading prices, PA8.F is priced at €0.04, while B8F.DE trades at €6.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas B8F.DE's P/E ratio is -32.40. In terms of profitability, PA8.F's ROE is +0.00%, compared to B8F.DE's ROE of -0.02%. Regarding short-term risk, PA8.F is less volatile compared to B8F.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check B8F.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, 21P1.F has a market cap of 19.6M. Regarding current trading prices, PA8.F is priced at €0.04, while 21P1.F trades at €0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas 21P1.F's P/E ratio is -0.01. In terms of profitability, PA8.F's ROE is +0.00%, compared to 21P1.F's ROE of -0.13%. Regarding short-term risk, PA8.F is less volatile compared to 21P1.F. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check 21P1.F's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, HOB0.F has a market cap of 17M. Regarding current trading prices, PA8.F is priced at €0.04, while HOB0.F trades at €0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas HOB0.F's P/E ratio is 6.30. In terms of profitability, PA8.F's ROE is +0.00%, compared to HOB0.F's ROE of -1.18%. Regarding short-term risk, PA8.F is more volatile compared to HOB0.F. This indicates potentially higher risk in terms of short-term price fluctuations for PA8.F.Check HOB0.F's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, B8FK.DE has a market cap of 15.4M. Regarding current trading prices, PA8.F is priced at €0.04, while B8FK.DE trades at €2.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas B8FK.DE's P/E ratio is -7.06. In terms of profitability, PA8.F's ROE is +0.00%, compared to B8FK.DE's ROE of -0.02%. Regarding short-term risk, PA8.F is less volatile compared to B8FK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check B8FK.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, SBX.DE has a market cap of 9.6M. Regarding current trading prices, PA8.F is priced at €0.04, while SBX.DE trades at €1.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas SBX.DE's P/E ratio is -1.22. In terms of profitability, PA8.F's ROE is +0.00%, compared to SBX.DE's ROE of -0.55%. Regarding short-term risk, PA8.F is less volatile compared to SBX.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check SBX.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, Z6A.F has a market cap of 4.5M. Regarding current trading prices, PA8.F is priced at €0.04, while Z6A.F trades at €0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas Z6A.F's P/E ratio is -0.02. In terms of profitability, PA8.F's ROE is +0.00%, compared to Z6A.F's ROE of -0.23%. Regarding short-term risk, PA8.F is less volatile compared to Z6A.F. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check Z6A.F's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, PA8.DE has a market cap of 2.7M. Regarding current trading prices, PA8.F is priced at €0.04, while PA8.DE trades at €0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas PA8.DE's P/E ratio is -0.13. In terms of profitability, PA8.F's ROE is +0.00%, compared to PA8.DE's ROE of -0.09%. Regarding short-term risk, PA8.F is less volatile compared to PA8.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check PA8.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, 2NU.F has a market cap of 1.1M. Regarding current trading prices, PA8.F is priced at €0.04, while 2NU.F trades at €0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas 2NU.F's P/E ratio is -0.03. In terms of profitability, PA8.F's ROE is +0.00%, compared to 2NU.F's ROE of N/A. Regarding short-term risk, PA8.F is less volatile compared to 2NU.F. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check 2NU.F's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, ERV2.F has a market cap of 329.9K. Regarding current trading prices, PA8.F is priced at €0.04, while ERV2.F trades at €0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas ERV2.F's P/E ratio is -0.02. In terms of profitability, PA8.F's ROE is +0.00%, compared to ERV2.F's ROE of +2.97%. Regarding short-term risk, PA8.F is more volatile compared to ERV2.F. This indicates potentially higher risk in terms of short-term price fluctuations for PA8.F.Check ERV2.F's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, MCD.DE has a market cap of 0. Regarding current trading prices, PA8.F is priced at €0.04, while MCD.DE trades at €0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas MCD.DE's P/E ratio is -0.02. In terms of profitability, PA8.F's ROE is +0.00%, compared to MCD.DE's ROE of -1.69%. Regarding short-term risk, PA8.F is less volatile compared to MCD.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PA8.F.Check MCD.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, 4XT.DE has a market cap of 0. Regarding current trading prices, PA8.F is priced at €0.04, while 4XT.DE trades at €0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas 4XT.DE's P/E ratio is -2.18. In terms of profitability, PA8.F's ROE is +0.00%, compared to 4XT.DE's ROE of -7.27%. Regarding short-term risk, PA8.F is more volatile compared to 4XT.DE. This indicates potentially higher risk in terms of short-term price fluctuations for PA8.F.Check 4XT.DE's competition here

PA8.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PA8.F stands at 259.7K. In comparison, BIO1.F has a market cap of 0. Regarding current trading prices, PA8.F is priced at €0.04, while BIO1.F trades at €36.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PA8.F currently has a P/E ratio of N/A, whereas BIO1.F's P/E ratio is -22.85. In terms of profitability, PA8.F's ROE is +0.00%, compared to BIO1.F's ROE of -0.08%. Regarding short-term risk, PA8.F is more volatile compared to BIO1.F. This indicates potentially higher risk in terms of short-term price fluctuations for PA8.F.Check BIO1.F's competition here